tiprankstipranks
Advertisement
Advertisement

HK:9989 Stock Latest News

Shenzhen Hepalink Clarifies 2025 Final Dividend Terms and Record Dates
Company AnnouncementsShenzhen Hepalink Clarifies 2025 Final Dividend Terms and Record Dates
2d ago
9989
Shenzhen Hepalink Announces Proposed Final Dividend for FY2025
PremiumCompany Announcements
Shenzhen Hepalink Announces Proposed Final Dividend for FY2025
3d ago
9989
Hepalink 2025 Profit Falls on API Weakness Despite Modest Revenue Growth
PremiumCompany Announcements
Hepalink 2025 Profit Falls on API Weakness Despite Modest Revenue Growth
3d ago
9989
Shenzhen Hepalink Sets March 30 Board Meeting to Approve 2025 Results and Weigh Dividend
PremiumCompany Announcements
Shenzhen Hepalink Sets March 30 Board Meeting to Approve 2025 Results and Weigh Dividend
17d ago
9989
Hepalink Sees 2025 Headline Profit Fall on One-Off Base, Underlying Earnings Surge on Heparin Growth
PremiumCompany Announcements
Hepalink Sees 2025 Headline Profit Fall on One-Off Base, Underlying Earnings Surge on Heparin Growth
2M ago
9989
Shenzhen Hepalink Approves Key Governance Changes at EGM
PremiumCompany AnnouncementsShenzhen Hepalink Approves Key Governance Changes at EGM
4M ago
9989
Shenzhen Hepalink Announces Board Composition and Roles
Premium
Company Announcements
Shenzhen Hepalink Announces Board Composition and Roles
4M ago
9989
Shenzhen Hepalink Proposes Governance Restructuring and Board Changes
Premium
Company Announcements
Shenzhen Hepalink Proposes Governance Restructuring and Board Changes
4M ago
9989
Shenzhen Hepalink Announces 2025 Extraordinary General Meeting
PremiumCompany Announcements
Shenzhen Hepalink Announces 2025 Extraordinary General Meeting
4M ago
9989
Shenzhen Hepalink Releases 2025 Q3 Financial Report
PremiumCompany Announcements
Shenzhen Hepalink Releases 2025 Q3 Financial Report
5M ago
9989
Shenzhen Hepalink Schedules Board Meeting to Review Q3 Results
PremiumCompany Announcements
Shenzhen Hepalink Schedules Board Meeting to Review Q3 Results
6M ago
9989
Shenzhen Hepalink Reports Decrease in Interim Financial Results for 2025
PremiumCompany Announcements
Shenzhen Hepalink Reports Decrease in Interim Financial Results for 2025
7M ago
9989
Shenzhen Hepalink to Review Interim Results and Consider Dividend
PremiumCompany AnnouncementsShenzhen Hepalink to Review Interim Results and Consider Dividend
8M ago
9989
Shenzhen Hepalink Advances H1710 Injection to Phase I Clinical Trial
Premium
Company Announcements
Shenzhen Hepalink Advances H1710 Injection to Phase I Clinical Trial
9M ago
9989
Shenzhen Hepalink Announces Final Dividend for 2024
Premium
Company Announcements
Shenzhen Hepalink Announces Final Dividend for 2024
9M ago
9989
Shenzhen Hepalink Gains EMA Authorization for Enoxaparin Sodium Injection
PremiumCompany Announcements
Shenzhen Hepalink Gains EMA Authorization for Enoxaparin Sodium Injection
10M ago
9989
Shenzhen Hepalink Pharmaceutical Group Approves Key Resolutions at 2024 AGM
PremiumCompany Announcements
Shenzhen Hepalink Pharmaceutical Group Approves Key Resolutions at 2024 AGM
11M ago
9989
Shenzhen Hepalink Updates Final Dividend Details for 2024
PremiumCompany Announcements
Shenzhen Hepalink Updates Final Dividend Details for 2024
11M ago
9989
Shenzhen Hepalink Announces 2024 AGM and Key Resolutions
PremiumCompany Announcements
Shenzhen Hepalink Announces 2024 AGM and Key Resolutions
11M ago
9989
Shenzhen Hepalink Releases 2025 Q1 Financial Report
PremiumCompany AnnouncementsShenzhen Hepalink Releases 2025 Q1 Financial Report
11M ago
9989
Shenzhen Hepalink’s Ivenoxin Gains Approval for South African Market
Premium
Company Announcements
Shenzhen Hepalink’s Ivenoxin Gains Approval for South African Market
11M ago
9989
Shenzhen Hepalink Schedules Board Meeting for Q1 Results
Premium
Company Announcements
Shenzhen Hepalink Schedules Board Meeting for Q1 Results
12M ago
9989

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >